A prospective, within-patient, crossover study of continuous intravenous and subcutaneous morphine for chronic cancer pain

Journal of Pain and Symptom Management
Kristine A NelsonEileen Groh

Abstract

The dose, efficacy, and side effects of continuous intravenous infusion (CIVI) of morphine were compared with continuous subcutaneous infusion (CSCI) of morphine in patients with chronic cancer pain. Eligible patients were referred to the Palliative Care Program and were receiving a stable dose of CIVI of morphine. The design was a within-patient, one-way crossover; in which each patient provided data before and after a switch from CIVI to CSCI of morphine. "Rescue" doses were 50% of the hourly dose given every 2 hours as needed. Morphine was infused intravenously (i.v.) and subcutaneously (s.c.) via a McGaw/AccuPro Volumetric Infusion Pump. After baseline data, including side effects and pain assessment, were obtained, patients were evaluated twice daily for toxicity and analgesic efficacy. Those who had a stable CIVI dose for 48 consecutive hr were crossed over to the CSCI at the same dose as the intravenous (i.v.) phase. A stable dose was defined as no dose change, four or less rescue doses in the previous 24 hr, and a pain rating of none or mild. CIVI was considered equal to CSCI if these criteria were maintained for 96 consecutive hr. Fifty-seven patients were entered, and 40 were evaluable (15 women and 25 men). The media...Continue Reading

References

Apr 14, 1979·British Medical Journal·J J Church
Apr 28, 1979·British Medical Journal·E N Fry
Jan 1, 1986·Journal of Pain and Symptom Management·V VentafriddaF De Conno
Nov 1, 1974·Journal of Clinical Pharmacology·S F BrunkW R Wilson
Jul 1, 1974·Clinical Pharmacology and Therapeutics·S F Brunk, M Delle
Apr 1, 1983·American Journal of Diseases of Children·A W MiserJ S Miser
Jan 1, 1984·Pain·T D Walsh
Jul 1, 1993·Journal of Pain and Symptom Management·E B Curtis, T D Walsh

❮ Previous
Next ❯

Citations

Sep 30, 2009·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Sasson Menahem, Pesach Shvartzman
Jan 24, 2009·Wiener medizinische Wochenschrift·Thomas Reif-Gintl, Wilfried Ilias
Nov 9, 2000·Journal of Pain and Symptom Management·S B LeGrandD S Zhukovsky
Dec 12, 2001·Journal of Pain and Symptom Management·C M Herndon, D S Fike
Jul 23, 2002·Journal of Palliative Medicine·David J CasarettKaren B Hirschman
Jan 1, 2009·Journal of Palliative Medicine·Henrique A ParsonsEduardo Bruera
Oct 24, 2002·The American Journal of Nursing·Chris Pasero
Oct 3, 2006·Current Opinion in Anaesthesiology·S J McGarrity, C J Glynn
May 4, 2010·The Lancet Oncology·Sebastiano Mercadante
Mar 28, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·P TucciL Romanelli
May 6, 2011·CA: a Cancer Journal for Clinicians·Judith A Paice, Betty Ferrell
Jul 28, 2016·European Journal of Internal Medicine·Sebastiano Mercadante
Apr 23, 2004·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·D CasarettD A Asch
Jun 1, 2005·Palliative Medicine·Caroline Fonzo-ChristePascal Bonnabry
May 4, 2004·The Annals of Pharmacotherapy·Stacey L Anderson, Scott T Shreve
Feb 15, 2007·The Annals of Pharmacotherapy·Asad E PatanwalaBrian L Erstad
Apr 29, 2015·The Cochrane Database of Systematic Reviews·Katharine KerIan Roberts
Dec 29, 1998·The American Journal of Hospice & Palliative Care·S G Mercadante
Aug 13, 2003·The American Journal of Hospice & Palliative Care·Susan B LeGrandMellar P Davis
Mar 20, 2020·The American Journal of Hospice & Palliative Care·Nayma Moya RomeroMichael A Silverman
May 25, 2005·The American Journal of Hospice & Palliative Care·Luiz Guilherme L Soares
May 2, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N ChernyUNKNOWN Expert Working Group of the European Association of Palliative Care Network
Feb 22, 2002·Cancer·Sebastiano MercadanteUNKNOWN Steering Committee of the European Association for Palliative Care (EAPC) Research Network
Mar 2, 2017·Drugs·Sebastiano Mercadante
Dec 2, 2008·Journal of Pain & Palliative Care Pharmacotherapy·Jesús González-BarboteoXavier Gómez-Batiste
Feb 22, 2013·Oncology Letters·Young Hak KimMichiaki Mishima

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.